Severe acute respiratory syndrome in children

Related Experiment Video

Updated: Sep 20, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Gary W K Wong1, Albert M Li, P C Ng

  • 1Department of Pediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. wingkinwong@cuhk.edu.hk

Pediatric Pulmonology
|September 2, 2003
PubMed

Insights

Severe acute respiratory syndrome (SARS) is a contagious disease caused by a novel coronavirus. While adults face severe illness and high mortality, children experience milder symptoms, with no reported fatalities.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Severe acute respiratory syndrome (SARS) is a novel, highly contagious respiratory infection.
  • Adults often develop progressive hypoxia and respiratory distress syndrome (RDS), with high mortality, particularly in the elderly.
  • The causative agent is a novel coronavirus, with transmission occurring through close contact with infected adults.

Purpose of the Study:

  • To describe the clinical presentation and outcomes of SARS in children.
  • To highlight the differences in disease severity between children and adults.
  • To emphasize the importance of public health measures in controlling SARS transmission.

Main Methods:

  • Observational analysis of pediatric SARS cases.
  • Review of clinical progression and treatment regimens.
  • Assessment of transmission dynamics within households.

Main Results:

  • Children infected with SARS typically present with milder illness compared to adults.
  • No case fatalities have been reported in children with SARS to date.
  • Early isolation of infected adults and strict public health policies are crucial for community control.

Conclusions:

  • SARS presents with significantly reduced severity in young children.
  • Effective management relies on prompt isolation of infected adults and robust public health interventions.
  • Further research into SARS pathophysiology and optimal treatment is warranted.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...